APA (7th ed.) Citation

LL, B. (2025). ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma-A Pathway to Improved Clinical Outcomes. Annals of surgical oncology, 32(7), 5269. https://doi.org/10.1245/s10434-025-17308-7

Chicago Style (17th ed.) Citation

LL, Bu. "ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma-A Pathway to Improved Clinical Outcomes." Annals of Surgical Oncology 32, no. 7 (2025): 5269. https://doi.org/10.1245/s10434-025-17308-7.

MLA (9th ed.) Citation

LL, Bu. "ASO Author Reflections: Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Squamous Cell Carcinoma-A Pathway to Improved Clinical Outcomes." Annals of Surgical Oncology, vol. 32, no. 7, 2025, p. 5269, https://doi.org/10.1245/s10434-025-17308-7.